AsianScientist (Oct. 26, 2016) – The Jackson Laboratory (JAX), a US-based nonprofit biomedical research institution, has announced a collaborative clinical genomics research agreement with the Wenzhou Municipal People’s Government, Ouhai District People’s Government (WZ), and Wenzhou Medical University and its affiliated hospitals (WMU).
Leveraging the research and scientific expertise of JAX and the clinical experience and expertise of WMU and its hospitals, the organizations will seek to better understand genomic propensities to disease and focus on individualized therapies for cancer, heart disease, and other afflictions. This will build on WMU’s increasing strength in life sciences research over the past few years.
The Jackson Laboratory-Wenzhou collaboration will take place in two phases. The first phase will entail hiring 75 to 100 new employees including principal investigators and scientific and administrative staff, and establishing a clinical research presence on the campus of WMU and in the Life & Health Town of Ouhai District, Wenzhou. JAX will initiate medical genomics research collaborations among WMU and JAX faculty both in the US and China.
In the second phase, JAX anticipates building its own laboratory supported by the Ouhai District and Wenzhou Medical University and hiring an additional 300 to 500 employees. The Life & Health Town is reserving space for this new facility in the planned development of a new Health Industry Innovation Center, an R&D incubator for the biomedical industry.
———
Source: The Jackson Laboratory; Photo: The Jackson Laboratory, Wenzhou Medical University.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.
